Juan Li Selected Research

Multiple Myeloma

1/2024	Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization.
1/2024	Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.
12/2023	Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.
10/2023	Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
3/2023	RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
2/2023	Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance.
1/2023	Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.
1/2023	Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era.
1/2023	Repetitive transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in multiple myeloma: A pilot study.
1/2023	On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Li Research Topics

Disease

593	Neoplasms (Cancer) 07/2024 - 02/2002
121	Inflammation (Inflammations) 05/2024 - 12/2005
117	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2006
116	Infections 05/2024 - 03/2006
78	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2008
70	Multiple Myeloma 01/2024 - 02/2002
58	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 09/2007
57	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 08/2004
56	Carcinogenesis 03/2024 - 06/2007
54	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2004
43	Hypoxia (Hypoxemia) 11/2023 - 12/2005
42	Pain (Aches) 03/2024 - 06/2006
42	Fibrosis (Cirrhosis) 03/2024 - 10/2004
41	Insulin Resistance 04/2024 - 11/2011
38	Lung Neoplasms (Lung Cancer) 03/2024 - 01/2011
36	COVID-19 01/2024 - 01/2020
35	Body Weight (Weight, Body) 01/2024 - 12/2010
32	Cognitive Dysfunction 03/2024 - 12/2005
32	Stomach Neoplasms (Stomach Cancer) 11/2023 - 06/2007
32	Carcinoma (Carcinomatosis) 09/2023 - 04/2002
31	Rheumatoid Arthritis 01/2024 - 08/2007
29	Hypertension (High Blood Pressure) 01/2023 - 03/2005
27	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 02/2007
26	Pancreatitis 05/2024 - 02/2011
26	Esophageal Squamous Cell Carcinoma 01/2022 - 07/2005
26	Leukemia 01/2021 - 06/2002
25	Stroke (Strokes) 04/2024 - 07/2004
24	Adenocarcinoma of Lung 07/2024 - 03/2014
23	Necrosis 05/2024 - 12/2007
23	Hemorrhage 11/2023 - 09/2007
22	Type 2 Diabetes Mellitus (MODY) 03/2024 - 06/2011
21	Non-alcoholic Fatty Liver Disease 12/2023 - 05/2012
20	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 01/2012
20	Atherosclerosis 03/2024 - 09/2003
20	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2008
20	Obesity 01/2023 - 10/2008
20	Ischemia 05/2020 - 04/2007
19	Wounds and Injuries (Trauma) 02/2024 - 03/2005
17	Myocardial Infarction 04/2024 - 03/2009
17	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 07/2012
17	Glioma (Gliomas) 12/2023 - 02/2002
17	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 04/2010
17	Neuroinflammatory Diseases 11/2023 - 01/2008
17	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023 - 09/2009
17	Rectal Neoplasms (Rectal Cancer) 02/2023 - 01/2014
16	Lung Injury 12/2023 - 09/2008
16	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 07/2011
16	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 02/2015
15	Disease Progression 07/2024 - 06/2015

Drug/Important Bio-Agent (IBA)

202	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2005
140	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2012
77	Long Noncoding RNAIBA 03/2024 - 07/2014
77	MicroRNAs (MicroRNA)IBA 11/2023 - 07/2010
61	Messenger RNA (mRNA)IBA 01/2023 - 05/2002
59	CytokinesIBA 05/2024 - 11/2008
53	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 11/2004
50	Therapeutic UsesIBA 04/2024 - 03/2005
47	DNA (Deoxyribonucleic Acid)IBA 07/2024 - 04/2002
37	VaccinesIBA 02/2024 - 01/2010
33	LipidsIBA 12/2023 - 10/2008
33	EnzymesIBA 12/2023 - 05/2002
31	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2006
31	LigandsIBA 03/2024 - 01/2008
30	Interleukin-6 (Interleukin 6)IBA 12/2023 - 02/2002
29	AntioxidantsIBA 11/2023 - 09/2003
28	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 11/2004
28	Insulin (Novolin)FDA Link 04/2023 - 11/2011
27	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024 - 12/2006
24	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023 - 12/2002
23	Bortezomib (Velcade)FDA Link 02/2023 - 04/2008
22	Small Interfering RNA (siRNA)IBA 03/2024 - 08/2006
22	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2009
22	Circular RNAIBA 01/2024 - 01/2019
22	AntigensIBA 01/2024 - 11/2002
20	Opioid Receptors (Opioid Receptor)IBA 12/2023 - 12/2010
20	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 06/2009
20	Transcription Factors (Transcription Factor)IBA 03/2023 - 05/2010
19	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2012
19	Indicators and Reagents (Reagents)IBA 12/2023 - 03/2006
18	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2019
18	CollagenIBA 04/2024 - 07/2013
18	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022 - 02/2011
17	Peptides (Polypeptides)IBA 05/2024 - 06/2009
17	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 12/2004
17	salicylhydroxamic acid (SHAM)IBA 01/2023 - 09/2011
16	HydrogelsIBA 04/2024 - 01/2016
16	Immunoglobulin G (IgG)IBA 03/2024 - 12/2002
16	Hormones (Hormone)IBA 12/2023 - 06/2012
16	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 07/2006
15	Analgesics (Analgesic Drugs)IBA 03/2024 - 06/2006
15	NF-kappa B (NF-kB)IBA 01/2024 - 09/2008

Therapy/Procedure

307	Therapeutics 07/2024 - 04/2004
103	Drug Therapy (Chemotherapy) 04/2024 - 08/2004
37	Immunotherapy 04/2024 - 11/2012
33	Radiotherapy 05/2024 - 08/2004
22	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 08/2007
18	Aftercare (After-Treatment) 01/2022 - 11/2007
16	Hematopoietic Stem Cell Transplantation 02/2023 - 06/2003
15	Neoadjuvant Therapy 04/2024 - 01/2019
15	Electroacupuncture 12/2023 - 06/2006